NYSE:HUMHumana Stock Price, Forecast & News

Humana's stock was trading at $328.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, HUM shares have increased by 20.8% and is now trading at $396.46. View which stocks have been most impacted by Coronavirus.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 6 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Humana.

Humana is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Humana.

Humana will be holding an earnings conference call on Wednesday, August 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Humana Inc (NYSE:HUM) released its earnings results on Wednesday, April, 29th. The insurance provider reported $5.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.84 by $0.56. The insurance provider had revenue of $18.94 billion for the quarter, compared to analysts' expectations of $18.49 billion. Humana had a net margin of 3.86% and a return on equity of 21.02%. Humana's revenue for the quarter was up 17.6% on a year-over-year basis. During the same quarter last year, the company earned $4.48 EPS. View Humana's earnings history.

Humana declared a quarterly dividend on Thursday, April 23rd. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.625 per share on Friday, July 31st. This represents a $2.50 annualized dividend and a yield of 0.63%. The ex-dividend date is Monday, June 29th. View Humana's dividend history.

Humana issued an update on its FY 2020 Pre-Market earnings guidance on Friday, May, 29th. The company provided earnings per share (EPS) guidance of 18.25-18.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $18.54.

20 analysts have issued 12-month price targets for Humana's shares. Their forecasts range from $290.00 to $510.00. On average, they expect Humana's share price to reach $412.05 in the next year. This suggests a possible upside of 3.9% from the stock's current price. View analysts' price targets for Humana.

News headlines about HUM stock have been trending negative recently, InfoTrie reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Humana earned a coverage optimism score of -2.1 on InfoTrie's scale. They also assigned headlines about the insurance provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Humana.

Humana saw a decrease in short interest in June. As of June 30th, there was short interest totaling 1,400,000 shares, a decrease of 33.3% from the June 15th total of 2,100,000 shares. Based on an average trading volume of 1,210,000 shares, the days-to-cover ratio is presently 1.2 days. Currently, 1.1% of the shares of the company are sold short. View Humana's Current Options Chain.

Some companies that are related to Humana include UnitedHealth Group (UNH), Cigna (CI), Anthem (ANTM), Centene (CNC), Molina Healthcare (MOH), Magellan Health (MGLN) and Triple-S Management (GTS). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Visa (V), Walt Disney (DIS), Alibaba Group (BABA), Mastercard (MA), Boeing (BA), salesforce.com (CRM), JPMorgan Chase & Co. (JPM) and CVS Health (CVS).

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Humana's stock is owned by a number of retail and institutional investors. Top institutional investors include State of Alaska Department of Revenue (0.02%), Municipal Employees Retirement System of Michigan (0.00%) and Ellevest Inc. (0.00%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James J /Ky Obrien, Roy A Beveridge, Timothy Alan Wheatley and Timothy S Huval. View institutional ownership trends for Humana.

HUM stock was sold by a variety of institutional investors in the last quarter, including Municipal Employees Retirement System of Michigan, and Ellevest Inc.. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, David A Jr/Ky Jones, Elizabeth D Bierbower, James J /Ky Obrien, Timothy Alan Wheatley, and Timothy S Huval. View insider buying and selling activity for Humana.

HUM stock was acquired by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. View insider buying and selling activity for Humana.

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of HUM stock can currently be purchased for approximately $396.46.

Humana has a market capitalization of $52.41 billion and generates $64.89 billion in revenue each year. The insurance provider earns $2.71 billion in net income (profit) each year or $17.87 on an earnings per share basis. Humana employs 46,000 workers across the globe.

The official website for Humana is www.humana.com.

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected]